Sign up
Pharma Capital

Nephros raises US$2.9mln; puts listing on national exchange in its sights

Nephros, Inc (OTCQB:NEPH) CFO Andy Astor tells Proactive Investors the medical-device company is taking in a US$2.9mln private placement.

Astor says the money will be used to shore up the company's balance sheet, potentially getting it to the point where it can up-list to a national exchange, as well as manage growth, increase inventory, and possibly pursue strategic opportunities.

 

View full NEPH profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.